StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
UZU.DE$59.00+1.72%
Fair $59.00+0.0%

UZU.DE

Uzin Utz SE

Basic Materials / Specialty ChemicalsXETRA

$59.00

+1.00 (+1.72%)

Fairly Valued+0.0%Fair Value $59.00Fund rank 29/100 · Data gapFallback financials|
SA 42/C
F-Score: 6/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 20%

FCF escenarios

weak_data · normalized FCF $28.5M · quality 52.3/100

Data gap 29/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 25/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

42/100

C

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists.
Thesis & Journal · UZU.DELocal privado en este navegador · Uzin Utz SE
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$298M

P/E

11.3x

↓

EV/EBITDA

5.4x

↓

ROE

9.0%

↑

Gross Margin

59.1%

↑

Debt/Equity

0.27

↑
52-Week Range$59
$58$88

TradingView lightweight chart

UZU.DE price, volumen y niveles de valoración

Último $59.00Periodo +247.5%
Fair value: $59.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+1.2%

FCF CAGR

—

FCF margin

2.5%

FCF / Net income

0.48x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $505.1M · net income $26.4M · FCF $12.8M

2022-FY → 2025-FY

Gross margin

59.1%+6.1% pts

Operating margin

7.9%+0.5% pts

Net margin

5.2%+0.0% pts

FCF margin

2.5%+9.4% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$505.1M$505.1M$476.0M$479.3M$487.1M
Net Income$26.4M$26.4M$29.4M$22.6M$25.3M
EBITDA$61.9M$61.9M$64.8M$53.5M$53.6M
EPS5.245.245.844.485.02
Gross Margin59.1%59.1%58.5%54.7%53.0%
Operating Margin7.9%7.9%8.9%7.2%7.4%
Net Margin5.2%5.2%6.2%4.7%5.2%
Balance Sheet
Debt/Equity0.270.270.290.370.40
Current Ratio1.871.87———
Cash Flow
Free Cash Flow$12.8M$12.8M$38.5M$28.5M$-33.7M
Returns
ROE9.0%9.0%10.5%8.8%10.5%
Valuation
P/E11.2611.268.3610.0910.32
EV/EBITDA5.385.384.365.346.20
P/B1.011.010.880.891.08
Growth & Yield
Revenue Growth6.1%6.1%-0.7%-1.6%—
EPS Growth-10.3%-10.3%30.4%-10.8%—
Dividend Yield3.3%3.3%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

-0.0%

fácil

EPS terminal req.

$5.24

Spread vs growth

-10.2%

5Y implied EPS CAGR

3.9%

fácil

EPS terminal req.

$6.33

Spread vs growth

-14.1%

10Y implied EPS CAGR

6.9%

razonable

EPS terminal req.

$10.20

Spread vs growth

-17.2%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -0.8%

Total return

-0.8%

Start / end P/E

10.5x → 11.3x

EPS bridge

5.84 → 5.24

Residual

-0.7%

EPS growth-10.3%
Multiple rerating+6.9%
Dividend+3.3%
Residual / FX / buybacks / cross-term-0.7%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.